Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) EBIAT (2016 - 2020)

Historic EBIAT for Forte Biosciences (FBRX) over the last 5 years, with Q1 2020 value amounting to -$10.3 million.

  • Forte Biosciences' EBIAT rose 3982.67% to -$10.3 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$56.7 million, marking a year-over-year decrease of 668.37%. This contributed to the annual value of -$63.5 million for FY2019, which is 2974.36% down from last year.
  • Forte Biosciences' EBIAT amounted to -$10.3 million in Q1 2020, which was up 3982.67% from -$10.6 million recorded in Q4 2019.
  • Forte Biosciences' 5-year EBIAT high stood at -$383000.0 for Q3 2018, and its period low was -$19.6 million during Q4 2018.
  • In the last 5 years, Forte Biosciences' EBIAT had a median value of -$10.3 million in 2020 and averaged -$11.5 million.
  • In the last 5 years, Forte Biosciences' EBIAT skyrocketed by 9615.19% in 2018 and then tumbled by 479164.49% in 2019.
  • Quarter analysis of 5 years shows Forte Biosciences' EBIAT stood at -$8.4 million in 2016, then decreased by 28.55% to -$10.8 million in 2017, then tumbled by 80.89% to -$19.6 million in 2018, then surged by 46.01% to -$10.6 million in 2019, then rose by 2.86% to -$10.3 million in 2020.
  • Its EBIAT was -$10.3 million in Q1 2020, compared to -$10.6 million in Q4 2019 and -$18.7 million in Q3 2019.